section name header

Basics

Outline


BASICS

Overview!!navigator!!

  • Several rare inherited coagulation deficiencies occur in horses:
    • vWD (vWF deficiency)—vWF is involved in platelet adhesion, and this defect results in abnormal platelet adhesion and platelet plug formation
    • Glanzmann thrombasthenia is a deficiency/dysfunction of the platelet glycoprotein IIb/IIIa complex, critical to platelet adhesion and aggregation
    • Hemophilia A (factor VIII deficiency) results in a defect in the intrinsic coagulation pathway, with deficient clot formation
    • Prekallikrein deficiency leads to defective initiation of the intrinsic coagulation pathway as this glycoprotein stimulates activation of factor XII
    • Protein C deficiency results in a hypercoagulable state and thrombotic events, as protein C is a critical coagulation inhibitor

Signalment!!navigator!!

  • Most disorders are inherited in an autosomal recessive pattern and occur in young purebred horses
  • Hemophilia A is most common, and has been diagnosed in Thoroughbred, Standardbred, Quarter Horse, Tennessee Walking Horse, and Arabian colts. It is an X-linked recessive chromosomal abnormality usually evident in colts <6 months of age (up to 3 years)
  • Prekallikrein deficiency has been reported in families of American Miniature and Belgian horses, affecting males and females. Horses with signs are homozygous, while heterozygous horses are asymptomatic
  • vWF deficiency has been reported in young Quarter Horses and Thoroughbreds
  • Glanzmann thrombasthenia has been reported in young and adult horses (Thoroughbred cross; Quarter Horse; Peruvian Paso; Oldenburg)
  • Protein C deficiency has been diagnosed in a Thoroughbred colt

Signs!!navigator!!

There are 3 clinical forms:

  • When the defect affects platelet function or primary hemostasis (e.g. vWF deficiency, Glanzmann thrombasthenia), signs are spontaneous epistaxis or bleeding involving mucosal surfaces and prolonged bleeding after trauma/surgery. Petechiae may be observed
  • When the defect affects clot formation or secondary hemostasis (e.g. hemophilia A), signs are a bleeding tendency with spontaneous hemorrhages or prolonged bleeding after trauma/surgery. Bleeding into body cavities, joints, muscles, and subcutaneously is common
  • When the defect is related to a coagulation inhibitor defect (e.g. protein C deficiency), signs are related to the subsequent hypercoagulable state (thrombosis)

Diagnosis

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

  • Disseminated intravascular coagulation (hemorrhagic form)—clinical signs and plasma d-dimer concentrations may aid differentiation
  • Acquired coagulation defects can be difficult to distinguish from inherited defects
  • Platelet disorders (e.g. thrombocytopenia) can be differentiated by platelet counts or tests of platelet function

CBC/Biochemistry/Urinalysis!!navigator!!

  • Few or no changes in CBC, serum biochemistry, and urinalysis
  • Most affected animals have normal platelet counts, but mild thrombocytopenia may be noted if profuse bleeding has occurred

Other Laboratory Tests!!navigator!!

  • vWD—prolonged TBT, normal to prolonged aPTT, and decreased plasma vWF antigen concentration
  • Glanzmann thrombasthenia—prolonged TBT but normal platelet count, PT, aPTT, and vWF antigen concentration. Platelet aggregation responses are markedly impaired
  • Hemophilia A—prolonged aPTT, normal PT, and reduced plasma factor VIII activity
  • Prekallikrein deficiency—prolonged aPTT, normal PT, and reduced plasma prekallikrein activity
  • Protein C deficiency—reduced plasma protein C activity and/or antigen concentration

Imaging!!navigator!!

Ultrasonography for suspected hematomas, hemothorax, or hemoperitoneum.

Other Diagnostic Procedures!!navigator!!

Cytology can confirm the presence of internal hemorrhage.

Treatment

TREATMENT

Potential treatments focus on restoration of the deficient factor by means of whole blood or plasma transfusions. Owners should be informed that these diseases have no cure.

Medications

MEDICATIONS

Contraindications/Possible Interactions

Other treatments affecting platelet function (e.g. colloids) or coagulation (e.g. heparin) may exacerbate bleeding tendency.

Follow-up

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

Continuous monitoring is indicated due to the risk of recurrent hemorrhage.

Prevention/Avoidance!!navigator!!

  • Affected animals and their parents should not be used for breeding
  • Preoperative blood transfusions may be necessary to reduce intrasurgical and postsurgical risk of bleeding

Expected Course and Prognosis!!navigator!!

There is no cure.

Miscellaneous

Outline


MISCELLANEOUS

Pregnancy/Fertility/Breeding!!navigator!!

N/A

Abbreviations!!navigator!!

  • aPTT = activated partial thromboplastin time
  • PT = prothrombin time
  • TBT = template bleeding time
  • vWD = von Willebrand disease
  • vWF = von Willebrand factor

Suggested Reading

Zimmel DN. Hemostatic disorders. In: Robinson NE, ed. Current Therapy in Equine Medicine, 5e. Philadelphia, PA: Saunders, 2003:351354.

Author(s)

Author: Eduard Jose-Cunilleras

Consulting Editors: David Hodgson, Harold C. McKenzie, and Jennifer L. Hodgson

Acknowledgment: The author and editors acknowledge the prior contribution of Luis Monreal.